- Inovio Pharmaceuticals (NASDAQ:INO) plans to offer common stock or pre-funded warrants in a public offering.
- Each share or warrant will be sold with accompanying Series A and Series B warrants.
- All securities in the offering will be sold by INOVIO, not
Inovio Pharmaceuticals announces proposed public offering of common stock and warrants

Related
Apple places supply chain strategist in chief operating offi...
7 minutes ago
0
Mobileye Q2 guidance range above consensus
10 minutes ago
0
Toll Brothers partners with International Capital to develop...
25 minutes ago
0
Brookfield set to take 20% stake in U.K. Sizewell C nuclear ...
27 minutes ago
0
Voya sees Q2 alternative investment income near long-term ex...
30 minutes ago
0
UK carrier Virgin Atlantic strikes deal with Musk's Starlink...
35 minutes ago
0
RxSight stock slides on lower Q2 revenue guidance
37 minutes ago
0
Penguin Solutions Non-GAAP EPS of $0.47 beats by $0.15, reve...
39 minutes ago
0
Granite awarded $111M Utah DOT project in Salt Lake City
42 minutes ago
0
Nasdaq's U.S. matched equity volume edges up in June
44 minutes ago
0
Cogent Biosciences announces $150M public offering of common...
45 minutes ago
0
Kura Sushi gains after posting an unexpected FQ3 profit
48 minutes ago
0
Presidio Property Trust 9.375% Preferred Series D declares $...
56 minutes ago
0
Trump doubles down on his Aug. 1 tariff deadline as stocks c...
58 minutes ago
0
Amazon’s tariff-clouded, seller-confused, AI-researched, wei...
58 minutes ago
0
Ellington Financial declares $0.13 dividend
1 hour ago
0
Procter & Gamble declares $1.0568 dividend
1 hour ago
0